By diminishing the migratory and invasive capacities of NSCLC cells, SLC7A11 knockdown could serve as a promising strategy to combat metastasis, which often complicates treatment outcomes in lung cancer patients. This evidence concerns the gene SLC7A11 and lung carcinoma.